A Japanese Study Assessing Glycemic Control with Use of IDegAsp Co-formulation in Patients with Type 2 Diabetes in Clinical Practice: The JAGUAR Study

INTRODUCTION: The aim of this study was to evaluate the glycemic control and safety of insulin degludec/insulin aspart (IDegAsp) co-formulation in Japanese patients with type 2 diabetes (T2D) in a real-world clinical setting, including elderly patients (aged > 75 years). METHODS: Patients (≥ 18 y...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaneko, Shizuka, da Rocha Fernandes, João D., Yamamoto, Yuiko, Langer, Jakob, Faurby, Mads
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932946/
https://www.ncbi.nlm.nih.gov/pubmed/33560496
http://dx.doi.org/10.1007/s12325-021-01623-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7932946/
https://www.ncbi.nlm.nih.gov/pubmed/33560496
http://dx.doi.org/10.1007/s12325-021-01623-y

Ejemplares similares